Skip to content

Prospective feasibility study of HYBRIDknifeflex-assisted gastric ESD using Gas-free Immersion and Flow-Assisted Coagulation

Prospective feasibility study of HYBRIDknifeflex-assisted gastric ESD using Gas-free Immersion and Flow-Assisted Coagulation - Prospective feasibility study of HYBRIDknifeflex-assisted gastric ESD using Gas-free Immersion and Flow-Assisted Coagulation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000061973
Enrollment
50
Registered
2026-06-20
Start date
2026-06-22
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric adenoma and early gastric cancer indicated for endoscopic submucosal dissection (ESD)

Interventions

Gastric ESD will be performed using HYBRIDknifeflex under the Gas-free Immersion (GFI) system. Flow-Assisted Coagulation (FAC) will be used for prophylactic coagulation and hemostasis when appropriate

Sponsors

Suzuka General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients aged 20 to 100 years. 2. Patients with gastric adenoma, early gastric cancer, or gastric epithelial neoplasms suspected of early gastric cancer. 3. Patients judged to be indicated for gastric ESD according to clinical practice and relevant guidelines. 4. Patients scheduled to undergo gastric ESD during hospitalization. 5. Patients who provide written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients for whom surgical treatment is considered more appropriate. 2. Patients with severe comorbidities precluding safe endoscopic treatment or sedation. 3. Patients with severe coagulation disorders or other conditions that make ESD unsafe. 4. Pregnant women or patients suspected of being pregnant. 5. Patients judged inappropriate for participation by the investigators.

Design outcomes

Primary

MeasureTime frame
Dissection speed (mm2min)

Secondary

MeasureTime frame
1. Procedure time 2. Resection time 3. Injection time 4. Hemostasis time 5. Number of intraoperative bleeding events 6. Total bleeding duration 7. Volume of injection solution 8. Number of hemostatic forceps uses 9. En bloc resection rate 10. R0 resection rate 11. Intraoperative perforation 12. Delayed bleeding 13. PECS 14. Aspiration pneumonia

Countries

Japan

Contacts

Public ContactTatsuma Nomura

Suzuka General Hospital Department of Gastroenterology

m06076tn@icloud.com0593821311

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Sep 19, 2026